Clinical Trial Update: Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of reloxaliase in enteric hyperoxaluria was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enteric Hyperoxaluria

Drugs mentioned

• rel oxaliase (rel oxaliase)

Snippet

Sponsor: Allena Pharmaceuticals | Conditions: Enteric Hyperoxaluria | Phase 3 | Status: TERMINATED